Christopher P Day
Overview
Explore the profile of Christopher P Day including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
121
Citations
11723
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Schwantes-An T, Whitfield J, Aithal G, Atkinson S, Bataller R, Botwin G, et al.
Hepatol Commun
. 2024 May;
8(6).
PMID: 38727677
Background: Polygenic Risk Scores (PRS) based on results from genome-wide association studies offer the prospect of risk stratification for many common and complex diseases. We developed a PRS for alcohol-associated...
2.
Anstee Q, Darlay R, Cockell S, Meroni M, Govaere O, Tiniakos D, et al.
J Hepatol
. 2023 Mar;
78(5):1085-1086.
PMID: 36922251
No abstract available.
3.
Whitfield J, Schwantes-An T, Darlay R, Aithal G, Atkinson S, Bataller R, et al.
J Hepatol
. 2022 Mar;
76(5):1244-1245.
PMID: 35287983
No abstract available.
4.
Govaere O, Petersen S, Martinez-Lopez N, Wouters J, Van Haele M, Mancina R, et al.
J Hepatol
. 2021 Dec;
76(5):1001-1012.
PMID: 34942286
Background & Aims: Obesity-associated inflammation is a key player in the pathogenesis of non-alcoholic fatty liver disease (NAFLD). However, the role of macrophage scavenger receptor 1 (MSR1, CD204) remains incompletely...
5.
Whitfield J, Schwantes-An T, Darlay R, Aithal G, Atkinson S, Bataller R, et al.
J Hepatol
. 2021 Oct;
76(2):275-282.
PMID: 34656649
Background & Aims: Only a minority of excess alcohol drinkers develop cirrhosis. We developed and evaluated risk stratification scores to identify those at highest risk. Methods: Three cohorts (GenomALC-1: n ...
6.
Anstee Q, Darlay R, Cockell S, Meroni M, Govaere O, Tiniakos D, et al.
J Hepatol
. 2021 Mar;
74(5):1274-1275.
PMID: 33678471
No abstract available.
7.
Govaere O, Cockell S, Tiniakos D, Queen R, Younes R, Vacca M, et al.
Sci Transl Med
. 2020 Dec;
12(572).
PMID: 33268509
The mechanisms that drive nonalcoholic fatty liver disease (NAFLD) remain incompletely understood. This large multicenter study characterized the transcriptional changes that occur in liver tissue across the NAFLD spectrum as...
8.
Whitfield J, Masson S, Liangpunsakul S, Mueller S, Aithal G, Eyer F, et al.
Am J Gastroenterol
. 2020 Sep;
116(1):106-115.
PMID: 32868629
Introduction: Sustained high alcohol intake is necessary but not sufficient to produce alcohol-related cirrhosis. Identification of risk factors, apart from lifetime alcohol exposure, would assist in discovery of mechanisms and...
9.
Schwantes-An T, Darlay R, Mathurin P, Masson S, Liangpunsakul S, Mueller S, et al.
Hepatology
. 2020 Aug;
73(5):1920-1931.
PMID: 32853455
Background And Aims: Only a minority of heavy drinkers progress to alcohol-associated cirrhosis (ALC). The aim of this study was to identify common genetic variants that underlie risk for ALC....
10.
Anstee Q, Darlay R, Cockell S, Meroni M, Govaere O, Tiniakos D, et al.
J Hepatol
. 2020 Apr;
73(3):505-515.
PMID: 32298765
Background & Aims: Genetic factors associated with non-alcoholic fatty liver disease (NAFLD) remain incompletely understood. To date, most genome-wide association studies (GWASs) have adopted radiologically assessed hepatic triglyceride content as...